—

Galenica Sante AG (GALE.SW) — the peer cohort

As of 2026-10-12 — scores re-bake nightly. Cohort = shared Closelooknet index membership first, then sector. Diary readings, not advice.

Galenica Sante AG ranks 9 of 9 in its cohort on the Closelooknet composite (44/100) — the cohort is led by Halozyme Therapeutics Inc at 74/100.

NameCompositeMomentumQualityValuationSignalOff 52w high
GALE.SW Galenica Sante AG 44 38 29 62 info 16.6%
SOON.SW Sonova H Ag 56 92 72 50 bull 0.3%
YPSN.SW Ypsomed Holding AG 56 69 62 28 info 13.7%
BANB.SW Bachem Holding AG 50 75 40 32 ok 3.8%
TECN.SW Tecan Group AG 48 93 27 52 ok 7.7%
HALO Halozyme Therapeutics Inc 74 94 94 48 ok 4.9%
DXCM DexCom Inc 66 85 80 35 bull 9.2%
LLY Eli Lilly and Company 64 73 91 27 bull 8.8%
ARGX.BR Argen-X 63 56 75 29 info 20.7%

Scores are relative readings across the Closelooknet coverage universe — methodology in the company-scoring explainer. Signal lights come from the nightly signal board.

FAQ · from the current data · as of 2026-10-12

Quick answers

Who are Galenica Sante AG's peers in the Closelooknet universe?

The cohort is drawn from shared Closelooknet index membership first, then sector: Sonova H Ag (SOON.SW), Ypsomed Holding AG (YPSN.SW), Bachem Holding AG (BANB.SW), Tecan Group AG (TECN.SW), Halozyme Therapeutics Inc (HALO), DexCom Inc (DXCM), Eli Lilly and Company (LLY), Argen-X (ARGX.BR).

How does GALE.SW score against its peers?

Galenica Sante AG's composite reads 44/100, ranking 9 of 9 in its cohort as of 2026-10-12; the cohort's highest composite is Halozyme Therapeutics Inc at 74/100. Closelooknet scores are research diary readings, not ratings or advice.

Related in the Closelooknet universe

then Medical Distribution, then Healthcare. Scored names rank on their Closelooknet score; names without one rank on trend state — above or below their 50- and 200-day averages — never on a score they do not carry.